First human test for potential breast cancer drug begins
Knowledge-focused
Completed
This early-stage study tested a new drug called Orialpha (BD-C) in 15 healthy adults to check its safety. The main goal was to find the highest dose people can take without serious side effects. This is the first step in research that could one day lead to a treatment for breast …
Phase: PHASE1 • Sponsor: Oriplantee Company Limited • Aim: Knowledge-focused
Last updated Mar 23, 2026 15:16 UTC